Fair Value Measurements and Investments - Schedule of Reconciliation For Contingent Consideration Measured At Fair Value Using Significant Unobservable Inputs (Level 3) (Detail) - Neo Medical [Member] - Fair Value, Inputs, Level 3 [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of convertible loans beginning balance	$ 7,140	$ 7,148
Interest recognized in interest income, net	496	436
Foreign currency remeasurement recognized in other income (expense), net	617	(67)
Unrealized gain (loss) recognized in other comprehensive income (loss)	(1,233)	294
Expected credit loss recognized in other income (expense), net	(260)
Conversion of Additional Convertible Loan into preferred equity securities		(671)
Fair value of convertible loans ending balance	6,760	7,140
Contractual value of Neo Medical Convertible Loans at December 31	7,020	5,907
Allowance for credit loss recognized in other income (expense), net	(260)
Amortized cost basis of Neo Medical Convertible Loans at December 31	$ 6,760	$ 5,907